Thurston Springer Miller Herd & Titak’s RXO RXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24K Hold
45
﹤0.01% 1150
2026
Q1
$657 Hold
45
﹤0.01% 1274
2025
Q4
$568 Buy
+45
New +$664 ﹤0.01% 1322
2025
Q3
Sell
-3,433
Closed -$54K 1206
2025
Q2
$54K Buy
3,433
+688
+25% +$10.4K 0.01% 654
2025
Q1
$52.4K Buy
2,745
+945
+53% +$20.7K 0.01% 619
2024
Q4
$42.9K Buy
1,800
+1,445
+407% +$40.3K 0.01% 563
2024
Q3
$9.94K Buy
355
+111
+45% +$3.13K ﹤0.01% 1037
2024
Q2
$6.38K Buy
+244
New +$5.08K ﹤0.01% 1133

Other funds holding RXO

Thurston Springer Miller Herd & Titak's RXO Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its RXO (RXO) position steady in Q2 2026 at 45 shares worth $1.24K. The position accounts for ﹤0.01% of the portfolio, ranked #1150.

Thurston Springer Miller Herd & Titak first reported a position in RXO in Q2 2024 and has held it in 8 quarters since. The position peaked at $54K in Q2 2025. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 45 shares of RXO worth $1.24K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak left its RXO share count unchanged in Q2 2026.
  • RXO made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #1150 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in RXO in Q2 2024 and has held it in 8 quarters since.
  • Thurston Springer Miller Herd & Titak's RXO position peaked at $54K in Q2 2025.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.